Clinical Trial Update: Expanded Access to Tavapadon

View source ↗

Summary

Expanded Access update for Tavapadon in Parkinson disease under AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Tavapadon (Tavapadon)

Snippet

Sponsor: AbbVie | Conditions: Parkinson Disease | Status: AVAILABLE